Alexandre Weinstein Manieu

CIK: 0001833124

Transaction Breakdown

Open Market Buys (P)3 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (13.3%)

Derivative conversions

Awards (A)8 (53.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (13.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PLUR

Pluri Inc.

Director10% Owner

PROC

Sofgen Pharma S.A.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (15 total)

PLUR
Pluri Inc.
Oct 23, 2026
Purchase(P)
Indirect
833.3K shares at avg. $1.50$1.3M
PLUR
Pluri Inc.
Aug 25, 2026
Exercise(M)
Direct
641 shares-
PLUR
Pluri Inc.
Aug 20, 2026
Award(A)
Direct
180K shares-
PLUR
Pluri Inc.
Jun 30, 2026
Expiration(E)
Warrants
Indirect
625K shares-
PLUR
Pluri Inc.
Jun 30, 2026
Award(A)
Direct
641 shares-
PLUR
Pluri Inc.
Apr 21, 2026
Award(A)
Indirect
312.5K shares at avg. $2.00$625K
PLUR
Pluri Inc.
Mar 31, 2026
Award(A)
Indirect
312.5K shares at avg. $2.00$625K
PLUR
Pluri Inc.
Dec 8, 2025
Award(A)
Indirect
625K shares at avg. $2.00$1.3M
PLUR
Pluri Inc.
Dec 4, 2025
Award(A)
Direct
519 shares-
PLUR
Pluri Inc.
Oct 29, 2025
Exercise(M)
Indirect
1M shares at avg. $0.00$100.217
PLUR
Pluri Inc.
Apr 28, 2025
Purchase(P)
Indirect
452.7K shares at avg. $4.61$2.1M
PLUR
Pluri Inc.
Apr 28, 2025
Purchase(P)
Indirect
523.4K shares at avg. $4.61$2.4M
PLUR
Pluri Inc.
Apr 28, 2025
Other(J)
Indirect
976.1K shares-
PLUR
Pluri Inc.
Feb 25, 2025
Award(A)
Direct
10.3K shares-
PLUR
Pluri Inc.
Jan 23, 2025
Award(A)
Common Warrants
Indirect
84.6K shares-

		Type	Shares	Price		Ownership
Oct 23, 2026	PLUR Pluri Inc.	Purchase(P)	833,334	$1.50	$1,250,001	Indirect
Aug 25, 2026	PLUR Pluri Inc.	Exercise(M)	641	-	$0	Direct
Aug 20, 2026	PLUR Pluri Inc.	Award(A)	180,000	-	$0	Direct
Jun 30, 2026	PLUR Pluri Inc.	Expiration(E) Warrants	625,000	-	-	Indirect
Jun 30, 2026	PLUR Pluri Inc.	Award(A)	641	-	$0	Direct
Apr 21, 2026	PLUR Pluri Inc.	Award(A)	312,500	$2.00	$625,000	Indirect
Mar 31, 2026	PLUR Pluri Inc.	Award(A)	312,500	$2.00	$625,000	Indirect
Dec 8, 2025	PLUR Pluri Inc.	Award(A)	625,000	$2.00	$1,250,000	Indirect
Dec 4, 2025	PLUR Pluri Inc.	Award(A)	519	-	-	Direct
Oct 29, 2025	PLUR Pluri Inc.	Exercise(M)	1,002,169	$0.00	$100	Indirect
Apr 28, 2025	PLUR Pluri Inc.	Purchase(P)	452,702	$4.61	$2,086,956	Indirect
Apr 28, 2025	PLUR Pluri Inc.	Purchase(P)	523,437	$4.61	$2,413,045	Indirect
Apr 28, 2025	PLUR Pluri Inc.	Other(J)	976,139	-	-	Indirect
Feb 25, 2025	PLUR Pluri Inc.	Award(A)	10,250	-	-	Direct
Jan 23, 2025	PLUR Pluri Inc.	Award(A) Common Warrants	84,599	-	-	Indirect

1-15 of 15 transactions

About Manieu Alexandre Weinstein

Manieu Alexandre Weinstein (SEC CIK 0001833124) files insider reports with the SEC as Director of Pluri Inc. (PLUR) and Director of Sofgen Pharma S.A. (PROC).

Signal8 holds 11 ownership filings by Manieu Alexandre Weinstein (2 Form 3, 9 Form 4), filed between Feb 18, 2025 and Oct 27, 2026. Those filings report 15 transactions, from Jan 23, 2025 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Manieu Alexandre Weinstein's filings is in OBBURGEN.

Recent filings by Manieu Alexandre Weinstein

Oct 23, 2026: Open-market purchase of PLUR shares (Form 4, code P).
Aug 25, 2026: Option exercise of PLUR shares (Form 4, code M).
Aug 20, 2026: Grant or award of PLUR shares (Form 4, code A).
Jun 30, 2026: Expiration of short derivative transaction of PLUR derivative securities (Form 4, code E).
Jun 30, 2026: Grant or award of PLUR shares (Form 4, code A).

Other insiders filing for Pluri Inc. (PLUR)

SHORRER DORON, Director
Ajchenbaum Eitan, Director
YANAY YAKY, Chief Executive Officer
Levi Rami Avraham, Director
Zalts Liat, Chief Financial Officer
Shemesh-Rasmussen Maital, Director

How to read Form 4 transaction codes